The role of non-nicotine tobacco smoke constituents in withdrawal and craving

非尼古丁烟草烟雾成分在戒断和渴望中的作用

基本信息

  • 批准号:
    9069787
  • 负责人:
  • 金额:
    $ 33.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-01 至 2019-05-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Tobacco use remains a major cause of premature death in the United States, with 30% of cancer deaths and 18% of all deaths directly attributable to smoking. Initiation of tobacco use occurs primarily during adolescence, with smoking rates peaking in young adults. Although tobacco smoke contains over 8000 constituents, most animal models used for testing smoking cessation therapies focus on the effects of nicotine alone in adult males. This lack of attention to both the non-nicotine constituents of tobacco and the age of first use may account for the low success rate of current tobacco cessation medications. With clinical data showing sex differences in tobacco dependence, it is also important to study females. Our group has been one of the only ones to examine the impact of non-nicotine constituents on nicotine actions in both adolescents and adults. We have shown that adult and adolescent rats will self-administer cigarette smoke extract (CSE), made by bubbling cigarette smoke through saline solution. CSE is more reinforcing in adult male rats than equivalent doses of nicotine alone, and animals that self-administered CSE are more sensitive to both stress- and nicotine-induced reinstatement of drug-seeking behavior than animals that worked for nicotine alone. Our data also suggest that both adolescents and adults exhibit more somatic withdrawal upon cessation of chronic CSE administration than nicotine. These findings indicate the importance of assessing the effects of nicotine in the presence of other tobacco smoke constituents. The objective of the current application is to examine mechanisms underlying enhanced withdrawal and drug-seeking behavior in animals that have been chronically treated with CSE. In addition to evaluating adolescent and adult males, we will initiate one of the first studies of the impact of CSE exposure in females. The specific aims of the proposal include: 1) Comparison of somatic and affective withdrawal symptoms following chronic nicotine and CSE exposure in adolescent and adult rats of both sexes. We will further test the hypotheses that monoamine oxidase inhibition, enhanced nicotinic acetylcholine and/or kappa opioid receptor function underlie the increased somatic withdrawal that we have observed following cessation of chronic CSE treatment in adult and adolescent males; 2) Comparison of stress-induced reinstatement of nicotine- and CSE-seeking behavior in adolescent and adult males, and assessment of the role of a3ß4 nicotinic receptors in mediating drug craving; 3) Establish a dose-response relationship for acquisition of self-administration of CSE, and equivalent doses of nicotine alone, in females. The approach is innovative in that it aims to bridge the gap between human and animal studies by examining the combined impact of tobacco smoke aqueous components. The proposed research is significant in that it provides an initial step towards a more comprehensive approach to determining neural mechanisms underlying tobacco dependence, and may result in the development of improved clinical therapies for smoking cessation.


项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FRANCES M. LESLIE其他文献

FRANCES M. LESLIE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FRANCES M. LESLIE', 18)}}的其他基金

Role of Monoamine Oxidases in Tobacco Addiction
单胺氧化酶在烟草成瘾中的作用
  • 批准号:
    7077928
  • 财政年份:
    2006
  • 资助金额:
    $ 33.5万
  • 项目类别:
Role of Monoamine Oxidases in Tobacco Addiction
单胺氧化酶在烟草成瘾中的作用
  • 批准号:
    7379939
  • 财政年份:
    2006
  • 资助金额:
    $ 33.5万
  • 项目类别:
Role of Monoamine Oxidases in Tobacco Addiction
单胺氧化酶在烟草成瘾中的作用
  • 批准号:
    7198110
  • 财政年份:
    2006
  • 资助金额:
    $ 33.5万
  • 项目类别:
Mechanisms of Adolescent Vulnerability to Drugs of Abuse
青少年容易滥用药物的机制
  • 批准号:
    6876286
  • 财政年份:
    2004
  • 资助金额:
    $ 33.5万
  • 项目类别:
Mechanisms of Adolescent Vulnerability to Drugs of Abuse
青少年容易滥用药物的机制
  • 批准号:
    7091632
  • 财政年份:
    2004
  • 资助金额:
    $ 33.5万
  • 项目类别:
Mechanisms of Adolescent Vulnerability to Drugs of Abuse
青少年容易滥用药物的机制
  • 批准号:
    6952449
  • 财政年份:
    2004
  • 资助金额:
    $ 33.5万
  • 项目类别:
Mechanisms of Adolescent Vulnerability to Drugs of Abuse
青少年容易滥用药物的机制
  • 批准号:
    7254794
  • 财政年份:
    2004
  • 资助金额:
    $ 33.5万
  • 项目类别:
Mechanisms of Adolescent Vulnerability to Drugs of Abuse
青少年容易滥用药物的机制
  • 批准号:
    7490294
  • 财政年份:
    2004
  • 资助金额:
    $ 33.5万
  • 项目类别:
Mechanisms of Adolescent Vulnerability to Drugs of Abuse
青少年容易滥用药物的机制
  • 批准号:
    7460735
  • 财政年份:
    2004
  • 资助金额:
    $ 33.5万
  • 项目类别:
ANIMAL MODELS OF NICOTINE SUSCEPTIBILITY
尼古丁敏感性的动物模型
  • 批准号:
    6660942
  • 财政年份:
    2002
  • 资助金额:
    $ 33.5万
  • 项目类别:

相似海外基金

Spatiotemporal dynamics of acetylcholine activity in adaptive behaviors and response patterns
适应性行为和反应模式中乙酰胆碱活性的时空动态
  • 批准号:
    24K10485
  • 财政年份:
    2024
  • 资助金额:
    $ 33.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Structural studies into human muscle nicotinic acetylcholine receptors
人体肌肉烟碱乙酰胆碱受体的结构研究
  • 批准号:
    MR/Y012623/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.5万
  • 项目类别:
    Research Grant
CRCNS: Acetylcholine and state-dependent neural network reorganization
CRCNS:乙酰胆碱和状态依赖的神经网络重组
  • 批准号:
    10830050
  • 财政年份:
    2023
  • 资助金额:
    $ 33.5万
  • 项目类别:
Study on biological significance of acetylcholine and the content in food resources
乙酰胆碱的生物学意义及其在食物资源中的含量研究
  • 批准号:
    23K05090
  • 财政年份:
    2023
  • 资助金额:
    $ 33.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
alpha7 nicotinic acetylcholine receptor allosteric modulation and native structure
α7烟碱乙酰胆碱受体变构调节和天然结构
  • 批准号:
    10678472
  • 财政年份:
    2023
  • 资助金额:
    $ 33.5万
  • 项目类别:
Diurnal Variation in Acetylcholine Modulation of Dopamine Dynamics Following Chronic Cocaine Intake
慢性可卡因摄入后乙酰胆碱对多巴胺动力学调节的昼夜变化
  • 批准号:
    10679573
  • 财政年份:
    2023
  • 资助金额:
    $ 33.5万
  • 项目类别:
Differential Nicotinic Acetylcholine Receptor Modulation of Striatal Dopamine Release as a Mechanism Underlying Individual Differences in Drug Acquisition Rates
纹状体多巴胺释放的烟碱乙酰胆碱受体差异调节是药物获取率个体差异的机制
  • 批准号:
    10553611
  • 财政年份:
    2022
  • 资助金额:
    $ 33.5万
  • 项目类别:
Striatal Regulation of Cortical Acetylcholine Release
纹状体对皮质乙酰胆碱释放的调节
  • 批准号:
    10549320
  • 财政年份:
    2022
  • 资助金额:
    $ 33.5万
  • 项目类别:
Structural basis of nicotinic acetylcholine receptor gating and toxin inhibition
烟碱乙酰胆碱受体门控和毒素抑制的结构基础
  • 批准号:
    10848770
  • 财政年份:
    2022
  • 资助金额:
    $ 33.5万
  • 项目类别:
Mechanisms of nicotinic acetylcholine receptor modulation of cocaine reward
烟碱乙酰胆碱受体调节可卡因奖赏的机制
  • 批准号:
    10672207
  • 财政年份:
    2022
  • 资助金额:
    $ 33.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了